AstraZeneca and Cognizant expand global services partnership
Cognizant, a leading US-based provider of consulting, technology and business process outsourcing services, has entered into a five-year agreement with AstraZeneca to provide application maintenance services to AZ's global enterprise in the areas of research, clinical development and sales and marketing.
Cognizant, a leading US-based provider of consulting, technology and business process outsourcing services, has entered into a five-year agreement with AstraZeneca to provide application maintenance services to AZ's global enterprise in the areas of research, clinical development and sales and marketing.
The new five-year deal expands the US$95m (Euro 75.5bn) agreement made in March, under which Cognizant provides centralised clinical data management services for all of AstraZeneca's global clinical development.Under the new agreement, Cognizant will work with AstraZeneca's Global Shared Services organisation and implement world class, end-to-end application maintenance services.
As part of this innovative agreement, Cognizant will adopt an "Outcome" or "Effect-based" model to provide these services by leveraging its global delivery network, talent pool and best practices. This, the company says, will ensure a predictable service model, reduce the overall cost of IT ownership, and deliver year-over-year efficiency improvements.
"The selection of Cognizant will allow us to leverage its global operations to meet the needs of our business and increase our focus on our core business," said Richard Williams, global cio at AstraZeneca.